中文|English
  • Home
  • About Us
    Return
    • Company Profile
    • Company Culture
    • CEO speech
    • Corporate Honors
    • Company strength
    • Structure
    • Global layout
    • Marketing network
  • Products
    Return
    • Anti-neoplastic Drug Series
    • Great health Series
    • Latest products
  • News
    Return
    • Company News
    • Industry News
  • Contact Us
  • Home
  • About Us
    Return
    • Company Profile
    • Company Culture
    • CEO speech
    • Corporate Honors
    • Company strength
    • Structure
    • Global layout
    • Marketing network
  • Products
    Return
    • Anti-neoplastic Drug Series
    • Great health Series
    • Latest products
  • News
    Return
    • Company News
    • Industry News
  • Contact Us
中文|English

News

A production technology of the company was granted national invention patent

Column:Company News Time:2014-07-02

Previous: Five kind of sterile bulk drug product and fourteen bulk drug product are approved by the national GMP certification
Next: Six kind of sterile bulk drug product(such as ceftriaxone sodium), are approved by the national GMP certification
About Us
Company profile
Company culture
CEO speech
Corporate honors
Company strength
Structure
Global layout
Marketing network
Products
Cephalosporin
Penicillin series
Intermediate
Anti tumor series
Big health Series
Latest products
News
Company News
Industry News
Environmental protection
Self monitoring
EIA publicity
Third party testing
Contact Us

Address: No. 1777 Kunming Road, Mudan District, Heze City, Shandong Province
Phone:400-6050-616
Email:service@rychem.com

Wechat
© 2024 Shandong Ruiying Pioneer Pharmaceutical Co.,Ltd.    37170202666888  ICP Number 10040251-1
鲁ICP备10040251号-1
TOP
0530-5852366
qrCode
sales@rychem.com